Smith & Nephew plc Share Price Today: Live Updates & Key Insights

Smith & Nephew plc share price today is $31.94, up -1.24%. The stock opened at $32.4 against the previous close of $32.34, with an intraday high of $32.4 and low of $31.8.

Smith & Nephew plc Share Price Chart

Smith & Nephew plc

us-stock
To Invest in {{usstockname}}
us-stock

Smith & Nephew plc Share Price Performance

$31.94 -0.0124(-1.24%) SNN at 23 Mar 2026 03:16 PM Medical Devices
Lowest Today 31.8
Highest Today 32.4
Today’s Open 32.4
Prev. Close 32.34
52 Week High 38.47
52 Week Low 23.71
Day’s Range: Low 31.8 High 32.4
52-Week Range: Low 23.71 High 38.47
1 day return -
1 Week return -3.53
1 month return -11.82
3 month return -3.58
6 month return -12.64
1 year return +13.92
3 year return +11.84
5 year return -15.53
10 year return -

Smith & Nephew plc Institutional Holdings

Bank of Montreal 0.77

BMO Capital Markets Corp. 0.77

River Road Asset Management, LLC 0.75

The Goldman Sachs Group Inc 0.46

Morgan Stanley - Brokerage Accounts 0.46

Scharf Investments 0.40

Brandes Investment Partners & Co 0.28

Bank of America Corp 0.23

Todd Asset Management 0.22

BNP Paribas Arbitrage, SA 0.22

ABC arbitrage SA 0.18

Dimensional Fund Advisors, Inc. 0.17

Arrowstreet Capital Limited Partnership 0.17

Northern Trust Corp 0.16

Causeway Capital Management LLC 0.14

Teachers Retirement System Of The State Of Kentucky 0.14

JPMorgan Chase & Co 0.13

FMR Inc 0.13

Royal Bank of Canada 0.12

QRG Capital Management, Inc. 0.12

Strategic Advisers U.S. Total Stock 0.07

AMG River Road Mid Cap Value N 0.05

Avantis International Equity ETF 0.04

JNL Multi-Manager Small Cap Value I 0.04

Heartland Mid Cap Value Institutional 0.04

AMG River Road Small-Mid Cap Value N 0.04

Brandes International ETF 0.04

Kingwest US Equity Portfolio Ser F 0.04

Buffalo International 0.04

River Road Small-Mid Cap Value II 0.03

Mercer US Small/Mid Cap Equity Y3 0.03

Dimensional International Core Eq 2 ETF 0.03

Dimensional Global Trgtd Value USD Acc 0.03

JNL Multi-Manager Mid Cap A 0.03

Aviva Investors US Eq Inc I 5 USD Inc 0.02

Stt Strt®SPDR®S&PKenshoNwEcosComposETF 0.02

Russell Inv Tax-Managed US Mid&Sm Cap S 0.02

Dimensional World ex US Core Eq 2 ETF 0.02

Scharf Global Opportunity ETF 0.02

EARNEST Partners International ADR 0.02

Smith & Nephew plc Market Status

Strong Buy: 1

Buy: 1

Hold: 2

Sell: 0

Strong Sell: 0

Smith & Nephew plc Fundamentals

Market Cap 13558.36 M

PB Ratio 2.5635

PE Ratio 22.3357

Enterprise Value 16345.03 M

Total Assets 10457.00 M

Volume 725915

Smith & Nephew plc Company Financials

Annual Revenue FY23:5549000000 5549.0M, FY22:5215000000 5215.0M, FY21:5212000000 5212.0M, FY20:4560000000 4560.0M, FY19:5138000000 5138.0M

Annual Profit FY23:3701000000 3701.0M, FY22:3675000000 3675.0M, FY21:3669000000 3669.0M, FY20:3164000000 3164.0M, FY19:3800000000 3800.0M

Annual Net worth FY23:263000000 263.0M, FY22:223000000 223.0M, FY21:524000000 524.0M, FY20:448000000 448.0M, FY19:600000000 600.0M

Quarterly Revenue Q2/2025:2987725000 2987.7M, Q2/2024:2827000000 2827.0M, Q1/2024:1413500000 1413.5M, Q4/2023:2792630483 2792.6M, Q2/2023:1367000000 1367.0M

Quarterly Profit Q2/2025:2109873000 2109.9M, Q2/2024:1974000000 1974.0M, Q1/2024:987000000 987.0M, Q4/2023:1905734692 1905.7M, Q2/2023:949000000 949.0M

Quarterly Net worth Q2/2025:295645000 295.6M, Q2/2024:214000000 214.0M, Q1/2024:107000000 107.0M, Q4/2023:90276864 90.3M, Q2/2023:86000000 86.0M

About Smith & Nephew plc & investment objective

Company Information Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Organisation Medical Devices

Employees 16988

Industry Medical Devices

CEO Dr. Deepak S. Nath Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Smith & Nephew plc FAQs

What is the share price of Smith & Nephew plc today?

The current share price of Smith & Nephew plc is $31.94.

Can I buy Smith & Nephew plc shares in India?

Yes, Indian investors can buy Smith & Nephew plc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Smith & Nephew plc shares in India?

You can easily invest in Smith & Nephew plc shares from India by:

Can I buy fractional shares of Smith & Nephew plc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Smith & Nephew plc?

Smith & Nephew plc has a market cap of $13558.36 M.

In which sector does Smith & Nephew plc belong?

Smith & Nephew plc operates in the Medical Devices sector.

What documents are required to invest in Smith & Nephew plc stocks?

To invest, you typically need:

What is the PE and PB ratio of Smith & Nephew plc?

The PE ratio of Smith & Nephew plc is 22.34 and the PB ratio is 2.56.